I've been suffering from snoring noise on my lung since contracting Covid – can this be cured?
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
OUR resident specialist and NHS GP, Dr Zoe Williams, shares her expert advice.
Today, Dr Zoe helps a reader developed an asthmatic type snoring noise post-Covid.
Sign up for Scottish Sun
newsletter
Sign up
2
Email your health queries to Dr Zoe Williams at health@thesun.co.uk
Credit: Olivia West
2
A reader, who has been suffering from an asthmatic type/snoring noise, writes in to Dr Zoe
Credit: Getty
Q)I'M a very fit 79-year-old male suffering from an asthmatic type/snoring noise on my lung, which I developed post-Covid.
It's more pronounced when I lie down in bed.
I go abroad every year in the hope the hot weather will dry my lungs, but without success.
I am not asthmatic. Can this be cured, or is it a side effect of statins which I have been taking for over two years?
A: Many different types of sounds can be heard in the lungs, which suggest a change in the way that air is flowing, and different sounds give clues towards different things.
A 'snoring' type sound would suggest mucus or something else is causing an obstruction.
Have you had it investigated?
If not, then you should, initially with an examination by your GP and a chest X-ray.
Statins can cause a lung disorder called interstitial lung disease, but it's a very rare side effect and the typical symptoms are cough, shortness of breath, fatigue, or loss of appetite with weight loss.
If you have any of these symptoms, it's important to let your GP know, as they can overlap with other lung diseases.
As you've had it for years and describe yourself as 'very fit' it's reassuring that it's unlikely to be sinister.
I'm a doctor - here's the anti-snoring exercises you need for a better night's sleep
TIP: Do you have a burning question about weight-loss jabs, like Ozempic?
Are you curious about the side effects, whether they're right for you, or how to best eat while you're on them?
I'm calling on Sun readers to send me their questions for a Live Q&A on the hot topic.
No question is too big, small or silly! Send your questions to me at the address below.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Leader Live
an hour ago
- Leader Live
BBC Radio Scotland presenter Bryan Burnett announces cancer diagnosis
The broadcaster, 59, announced on Thursday that he would be stepping back from his early evening programme Get It On to undergo appendiceal cancer treatment. Speaking on air, he said the tumour was first discovered earlier this year while he was having surgery to remove his appendix. He said: 'Appendix cancer is incredibly rare but the good news is it is treatable, but I do have to have some fairly hefty abdominal surgery next week. 'It's going to mean I am going to be off work for a couple of months and you know how hard I will find that. However, I'm expected to make a full recovery, which is good news, and will be back on air, on the show that I truly love, later in the year. 'Those of you who are regular listeners know that we are such a close team on Get It On, so I also want to take this opportunity to say a massive thank you to my brilliant producers for all the hand-holding and encouragement they've given me since they found out my news. I'm sure they will let you know how I'm doing over the next few weeks.' In a statement he said his treatment will begin next week and will involve abdominal surgery and chemotherapy. Burnett said: 'I've experienced the most incredible care and kindness from the NHS staff who have been looking after me. 'My surgeon is a Get It On listener so I know I'm in good hands. 'I will really miss the music and the chat when I'm off but our listeners have given me hundreds of great playlists so that will keep me going over the next few months.' Broadcaster Grant Stott will step in to present the show in his absence. Hayley Valentine, director BBC Scotland, said: 'Bryan is one of our most popular broadcasters on Radio Scotland and I know listeners will join us in wishing him well as he embarks on his treatment. 'We look forward to welcoming him back to the Get It On studio once he's recovered.'
Glasgow Times
an hour ago
- Glasgow Times
Vaginal mesh particles ‘could trigger autoimmune response even after removal'
Experts suggest allergy testing patients before they are fitted with mesh may help to better understand why complications happen in some cases. Campaign group Sling the Mesh said the majority of its members have developed a reaction they believe is down to the material, including autoimmune diseases, unexplained rashes and chronic fatigue. Transvaginal mesh (TVM) implants are made from synthetic materials such as polypropylene, a type of thermoplastic, and have been used to treat pelvic organ prolapse and incontinence after childbirth. However, they can cause serious harm to some women, with side effects including infection, pelvic pain, and incontinence. The NHS restricted its use of TVM implants in 2018 and they are now used only as a last resort through a high-vigilance programme of restricted practice. A new article led by Dr Nicholas Farr, published in the journal Nature Reviews Urology, analysed studies which suggest polypropylene is a material which causes autoimmune/inflammatory syndrome induced by adjuvants (Asia). Asia arises following exposure to substances that enhance the immune response in the likes of vaccines, silicone implants, or other foreign materials. Symptoms can vary widely, but include chronic fatigue and chronic pain. It comes after previous work by Dr Farr, who is a research fellow at the University of Sheffield, showed polypropylene mesh started to degrade within 60 days of being implanted in the pelvis of sheep. The study also found particles of polypropylene in the tissue surrounding implant sites. Dr Farr told the PA news agency: 'Our previous studies have shown that polypropylene mesh can degrade and leave behind particles within the surrounding tissues. 'This is important because it raises a key question – what kind of clinical response might these particles trigger?' 'Earlier studies have explored links between mesh implants and systemic symptoms resembling Asia. Patients often reported that symptoms improved after mesh removal, but in some cases, they didn't fully resolve. 'These cases were described as involving 'complete' mesh removal. But our findings challenge that definition. 'We've shown that even after the mesh has been surgically removed, polypropylene particles can persist in the tissue. 'So, it may not be a truly complete removal – and that could help explain why symptoms persist in a subset of patients. 'Our findings offer a new perspective on earlier studies, suggesting that residual particles might be a contributing factor in ongoing immune responses, even after the visible mesh is gone.' Dr Farr called for 'increased clinical surveillance of mesh patients' to keep track of any autoimmune symptoms, as well as allergy tests to consider suitability before they are implanted. He added: 'While it is important to recognise that the majority of mesh implants do not result in serious complications, we need to better understand why complications arise in a subset of patients and ensure those experiences are not overlooked. 'It is also essential that we engage with patients who have lived experience of mesh complications, as their insights are vital to improving future care and guiding the responsible development of safer medical devices.' Reacting to Dr Farr's latest findings, Kath Sansom, founder of campaign group Sling The Mesh, told PA it 'confirms what thousands of mesh injured patients have been reporting for years – that polypropylene mesh can lead to autoimmune disease, fibromyalgia and allergic reactions'. 'For too long, our voices have been dismissed,' she added. 'Now, science is catching up, and it's imperative that regulators and manufacturers take immediate action to prevent further harm.' Ms Sansom told PA the findings underscore the need for revaluation of the material used in mesh, along with the importance of 'patient-centred approaches'. 'The majority of our group – nearly 12,000 people – have developed some sort of reaction believed to be from the plastic mesh including a wide range of autoimmune diseases, unexplained rashes, IBS, dry eyes and chronic fatigue,' she added. Sharron Mahoney, 57, claims the vaginal mesh she had implanted in 2010 caused her immune system to go 'into overdrive', with symptoms either easing or disappearing when she had it removed in 2018. She said: 'After receiving a rectopexy mesh implant, I began suffering from a host of unexplained symptoms – severe fatigue, joint pain, recurring rashes, and food and chemical sensitivities that I had never experienced before. 'I couldn't grip anything, was losing my vision, had chronic cough, post nasal drip. Dry eyes. Stiff and sore muscles. Rashes on my skin. 'Doctors struggled to find a cause and treated me like a mystery – I later found out they put 'may be psychological' in my notes. 'When I finally had the mesh removed, the change was extraordinary – the allergic reactions instantly eased, my energy slowly returned, and many of the autoimmune symptoms diminished or disappeared entirely. 'My experience has left me in no doubt that the mesh was causing my immune system to go into overdrive. 'Patients need to be heard, and we need robust, long-term research and regulation to prevent others from suffering needlessly.' A 2024 report by Patient Safety Commissioner Dr Henrietta Hughes highlighted that thousands of women's lives were 'destroyed' because of pelvic mesh. It called for the Government to create a two-stage financial redress scheme. However, in February – a year on from the report's publication – campaigners said they have 'faced silence', with no compensation scheme put in place.
Leader Live
an hour ago
- Leader Live
Vaginal mesh particles ‘could trigger autoimmune response even after removal'
Experts suggest allergy testing patients before they are fitted with mesh may help to better understand why complications happen in some cases. Campaign group Sling the Mesh said the majority of its members have developed a reaction they believe is down to the material, including autoimmune diseases, unexplained rashes and chronic fatigue. Transvaginal mesh (TVM) implants are made from synthetic materials such as polypropylene, a type of thermoplastic, and have been used to treat pelvic organ prolapse and incontinence after childbirth. However, they can cause serious harm to some women, with side effects including infection, pelvic pain, and incontinence. The NHS restricted its use of TVM implants in 2018 and they are now used only as a last resort through a high-vigilance programme of restricted practice. A new article led by Dr Nicholas Farr, published in the journal Nature Reviews Urology, analysed studies which suggest polypropylene is a material which causes autoimmune/inflammatory syndrome induced by adjuvants (Asia). Asia arises following exposure to substances that enhance the immune response in the likes of vaccines, silicone implants, or other foreign materials. Symptoms can vary widely, but include chronic fatigue and chronic pain. It comes after previous work by Dr Farr, who is a research fellow at the University of Sheffield, showed polypropylene mesh started to degrade within 60 days of being implanted in the pelvis of sheep. The study also found particles of polypropylene in the tissue surrounding implant sites. Dr Farr told the PA news agency: 'Our previous studies have shown that polypropylene mesh can degrade and leave behind particles within the surrounding tissues. 'This is important because it raises a key question – what kind of clinical response might these particles trigger?' 'Earlier studies have explored links between mesh implants and systemic symptoms resembling Asia. Patients often reported that symptoms improved after mesh removal, but in some cases, they didn't fully resolve. 'These cases were described as involving 'complete' mesh removal. But our findings challenge that definition. 'We've shown that even after the mesh has been surgically removed, polypropylene particles can persist in the tissue. 'So, it may not be a truly complete removal – and that could help explain why symptoms persist in a subset of patients. 'Our findings offer a new perspective on earlier studies, suggesting that residual particles might be a contributing factor in ongoing immune responses, even after the visible mesh is gone.' Dr Farr called for 'increased clinical surveillance of mesh patients' to keep track of any autoimmune symptoms, as well as allergy tests to consider suitability before they are implanted. He added: 'While it is important to recognise that the majority of mesh implants do not result in serious complications, we need to better understand why complications arise in a subset of patients and ensure those experiences are not overlooked. 'It is also essential that we engage with patients who have lived experience of mesh complications, as their insights are vital to improving future care and guiding the responsible development of safer medical devices.' Reacting to Dr Farr's latest findings, Kath Sansom, founder of campaign group Sling The Mesh, told PA it 'confirms what thousands of mesh injured patients have been reporting for years – that polypropylene mesh can lead to autoimmune disease, fibromyalgia and allergic reactions'. 'For too long, our voices have been dismissed,' she added. 'Now, science is catching up, and it's imperative that regulators and manufacturers take immediate action to prevent further harm.' Ms Sansom told PA the findings underscore the need for revaluation of the material used in mesh, along with the importance of 'patient-centred approaches'. 'The majority of our group – nearly 12,000 people – have developed some sort of reaction believed to be from the plastic mesh including a wide range of autoimmune diseases, unexplained rashes, IBS, dry eyes and chronic fatigue,' she added. Sharron Mahoney, 57, claims the vaginal mesh she had implanted in 2010 caused her immune system to go 'into overdrive', with symptoms either easing or disappearing when she had it removed in 2018. She said: 'After receiving a rectopexy mesh implant, I began suffering from a host of unexplained symptoms – severe fatigue, joint pain, recurring rashes, and food and chemical sensitivities that I had never experienced before. 'I couldn't grip anything, was losing my vision, had chronic cough, post nasal drip. Dry eyes. Stiff and sore muscles. Rashes on my skin. 'Doctors struggled to find a cause and treated me like a mystery – I later found out they put 'may be psychological' in my notes. 'When I finally had the mesh removed, the change was extraordinary – the allergic reactions instantly eased, my energy slowly returned, and many of the autoimmune symptoms diminished or disappeared entirely. 'My experience has left me in no doubt that the mesh was causing my immune system to go into overdrive. 'Patients need to be heard, and we need robust, long-term research and regulation to prevent others from suffering needlessly.' A 2024 report by Patient Safety Commissioner Dr Henrietta Hughes highlighted that thousands of women's lives were 'destroyed' because of pelvic mesh. It called for the Government to create a two-stage financial redress scheme. However, in February – a year on from the report's publication – campaigners said they have 'faced silence', with no compensation scheme put in place.
